These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15733558)

  • 21. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
    Wasan KM; Risovic V; Yuen VG; McNeill JH
    J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term treatment with dipeptidyl peptidase IV inhibitor improves hepatic and peripheral insulin sensitivity in the VDF Zucker rat: a euglycemic-hyperinsulinemic clamp study.
    Pospisilik JA; Stafford SG; Demuth HU; McIntosh CH; Pederson RA
    Diabetes; 2002 Sep; 51(9):2677-83. PubMed ID: 12196458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats: A comparison with PPAR gamma agonism.
    Bergeron R; Yao J; Woods JW; Zycband EI; Liu C; Li Z; Adams A; Berger JP; Zhang BB; Moller DE; Doebber TW
    Endocrinology; 2006 Sep; 147(9):4252-62. PubMed ID: 16728496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral administration of the biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats.
    Clodfelder BJ; Gullick BM; Lukaski HC; Neggers Y; Vincent JB
    J Biol Inorg Chem; 2005 Mar; 10(2):119-30. PubMed ID: 15625608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of S 15511, a therapeutic metabolite of the insulin-sensitizing agent S 15261, in the Zucker Diabetic Fatty rat.
    Pickavance LC; Wilding JP
    Diabetes Obes Metab; 2007 Jan; 9(1):114-20. PubMed ID: 17199726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes.
    Singh S; Roy S; Sethi S; Benjamin B; Sundaram S; Khanna V; Kandalkar SR; Pal C; Kant R; Patra AK; Rayasam G; Mittra S; Saini KS; Paliwal J; Chugh A; Ahmed S; Sattigeri J; Cliff I; Ray A; Bansal VS; Bhatnagar PK; Davis JA
    Eur J Pharmacol; 2011 Feb; 652(1-3):157-63. PubMed ID: 20540938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent intermittent restraint delays fed and fasting hyperglycemia and improves glucose return to baseline levels during glucose tolerance tests in the Zucker diabetic fatty rat--role of food intake and corticosterone.
    Bates HE; Kiraly MA; Yue JT; Goche Montes D; Elliott ME; Riddell MC; Matthews SG; Vranic M
    Metabolism; 2007 Aug; 56(8):1065-75. PubMed ID: 17618951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lifelong sequential changes in glucose tolerance and insulin secretion in genetically obese Zucker rats (fa/fa) fed a diabetogenic diet.
    Fürnsinn C; Komjati M; Madsen OD; Schneider B; Waldhäusl W
    Endocrinology; 1991 Feb; 128(2):1093-9. PubMed ID: 1989847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isosteviol reduces plasma glucose levels in the intravenous glucose tolerance test in Zucker diabetic fatty rats.
    Ma J; Ma Z; Wang J; Milne RW; Xu D; Davey AK; Evans AM
    Diabetes Obes Metab; 2007 Jul; 9(4):597-9. PubMed ID: 17587403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved glucose tolerance via enhanced glucose-dependent insulin secretion in dipeptidyl peptidase IV-deficient Fischer rats.
    Nagakura T; Yasuda N; Yamazaki K; Ikuta H; Yoshikawa S; Asano O; Tanaka I
    Biochem Biophys Res Commun; 2001 Jun; 284(2):501-6. PubMed ID: 11394909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preservation of insulin secretory responses to P2 purinoceptor agonists in Zucker diabetic fatty rats.
    Tang J; Pugh W; Polonsky KS; Zhang H
    Am J Physiol; 1996 Mar; 270(3 Pt 1):E504-12. PubMed ID: 8638699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo administration of the C16:0 fatty acid isoform of sulfatide increases pancreatic sulfatide and enhances glucose-stimulated insulin secretion in Zucker fatty (fa/fa) rats.
    Blomqvist M; Carrier M; Andrews T; Pettersson K; Månsson JE; Rynmark BM; Fredman P; Buschard K
    Diabetes Metab Res Rev; 2005; 21(2):158-66. PubMed ID: 15580649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone.
    Sreenan S; Sturis J; Pugh W; Burant CF; Polonsky KS
    Am J Physiol; 1996 Oct; 271(4 Pt 1):E742-7. PubMed ID: 8897863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dipeptidyl peptidase-4 inhibition in diabetic rats leads to activation of the transcription factor CREB in β-cells.
    Pugazhenthi S; Qin L; Bouchard R
    Eur J Pharmacol; 2015 May; 755():42-9. PubMed ID: 25720341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TMG-123, a novel glucokinase activator, exerts durable effects on hyperglycemia without increasing triglyceride in diabetic animal models.
    Tsumura Y; Tsushima Y; Tamura A; Hasebe M; Kanou M; Kato H; Kobayashi T
    PLoS One; 2017; 12(2):e0172252. PubMed ID: 28207836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of gonadectomy on glucose tolerance of genetically obese (fa/fa) rats: influence of sex and genetic background.
    Kava RA; West DB; Lukasik VA; Wypijewski C; Wojnar Z; Johnson PR; Greenwood MR
    Int J Obes Relat Metab Disord; 1992 Feb; 16(2):103-11. PubMed ID: 1316324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Capsiate improves glucose metabolism by improving insulin sensitivity better than capsaicin in diabetic rats.
    Kwon DY; Kim YS; Ryu SY; Cha MR; Yon GH; Yang HJ; Kim MJ; Kang S; Park S
    J Nutr Biochem; 2013 Jun; 24(6):1078-85. PubMed ID: 23026494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic and endocrine effects of interleukin-1 in obese, diabetic Zucker fa/fa rats.
    del Rey A; Monge-Arditi G; Klusman I; Besedovsky HO
    Exp Clin Endocrinol Diabetes; 1996; 104(4):317-26. PubMed ID: 8886749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of glucose intolerance in obese (fa/fa) Zucker rats.
    Apweiler R; Freund P
    Horm Metab Res; 1993 Oct; 25(10):521-4. PubMed ID: 8262460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.